177 related articles for article (PubMed ID: 25490867)
1. Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry workup.
Eidenschink Brodersen L; Menssen AJ; Wangen JR; Stephenson CF; de Baca ME; Zehentner BK; Wells DA; Loken MR
Cytometry B Clin Cytom; 2015 Mar; 88(2):125-35. PubMed ID: 25490867
[TBL] [Abstract][Full Text] [Related]
2. Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry work-up.
Eidenschink Brodersen L; Menssen AJ; Wangen JR; Stephenson CF; de Baca ME; Zehentner BK; Wells DA; Loken MR
Cytometry B Clin Cytom; 2014 Oct; ():. PubMed ID: 25336233
[TBL] [Abstract][Full Text] [Related]
3. Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation.
Wangen JR; Eidenschink Brodersen L; Stolk TT; Wells DA; Loken MR
Int J Lab Hematol; 2014 Apr; 36(2):184-96. PubMed ID: 24118926
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.
Malcovati L; Della Porta MG; Lunghi M; Pascutto C; Vanelli L; Travaglino E; Maffioli M; Bernasconi P; Lazzarino M; Invernizzi R; Cazzola M
Leukemia; 2005 May; 19(5):776-83. PubMed ID: 15789068
[TBL] [Abstract][Full Text] [Related]
5. Analysis of erythroid maturation in the nonlysed bone marrow with help of radar plots facilitates detection of flow cytometric aberrations in myelodysplastic syndromes.
Violidaki D; Axler O; Jafari K; Bild F; Nilsson L; Mazur J; Ehinger M; Porwit A
Cytometry B Clin Cytom; 2020 Sep; 98(5):399-411. PubMed ID: 32543774
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome.
Della Porta MG; Malcovati L; Invernizzi R; Travaglino E; Pascutto C; Maffioli M; Gallì A; Boggi S; Pietra D; Vanelli L; Marseglia C; Levi S; Arosio P; Lazzarino M; Cazzola M
Leukemia; 2006 Apr; 20(4):549-55. PubMed ID: 16498394
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.
Westers TM; Cremers EM; Oelschlaegel U; Johansson U; Bettelheim P; Matarraz S; Orfao A; Moshaver B; Brodersen LE; Loken MR; Wells DA; Subirá D; Cullen M; Te Marvelde JG; van der Velden VH; Preijers FW; Chu SC; Feuillard J; Guérin E; Psarra K; Porwit A; Saft L; Ireland R; Milne T; Béné MC; Witte BI; Della Porta MG; Kern W; van de Loosdrecht AA;
Haematologica; 2017 Feb; 102(2):308-319. PubMed ID: 27758818
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 and CD35 during normal and myelodysplastic erythropoiesis.
Laranjeira P; Rodrigues R; Carvalheiro T; Constanço C; Vitória H; Matarraz S; Trindade H; Órfão A; Paiva A
Leuk Res; 2015 Mar; 39(3):361-70. PubMed ID: 25582385
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V
Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225
[TBL] [Abstract][Full Text] [Related]
10. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
Lu D; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
Xu F; Wu L; He Q; Zhang Z; Chang C; Li X
Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
[TBL] [Abstract][Full Text] [Related]
12. [Application of flow cytometry in detecting dysplasia of myelodysplastic syndromes].
Li J; He GS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1069-72. PubMed ID: 23998614
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
[TBL] [Abstract][Full Text] [Related]
14. Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms.
Kern W; Bacher U; Schnittger S; Alpermann T; Haferlach C; Haferlach T
Cytometry B Clin Cytom; 2013 May; 84(3):194-7. PubMed ID: 23283847
[TBL] [Abstract][Full Text] [Related]
15. Qualitative flow cytometric analysis of Malaysian myelodysplastic syndromes (MDS) patients.
Mohadese Hashem B; Rajesh R; Sabariah MN; Zainina BS
Med J Malaysia; 2012 Feb; 67(1):77-80. PubMed ID: 22582553
[TBL] [Abstract][Full Text] [Related]
16. A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.
Kárai B; Bedekovics J; Miltényi Z; Gergely L; Szerafin L; Ujfalusi A; Kappelmayer J; Hevessy Z
Int J Lab Hematol; 2017 Dec; 39(6):577-584. PubMed ID: 28625017
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
[TBL] [Abstract][Full Text] [Related]
18. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes.
Alhan C; Westers TM; Cremers EM; Cali C; Witte BI; Ossenkoppele GJ; van de Loosdrecht AA
Br J Haematol; 2014 Oct; 167(1):100-9. PubMed ID: 24976502
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
Della Porta MG; Lanza F; Del Vecchio L;
Cytometry B Clin Cytom; 2011; 80(4):201-11. PubMed ID: 21674774
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]